XML 41 R29.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Financial Instruments and Derivative Instruments (Tables) | 9 Months Ended
--- | ---
Sep. 25, 2022
Financial Instruments and Derivative Instruments |
Schedule of fair value of financial assets and liabilities | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Fair Value Measurement at September 25, 2022 Using:
​ | ​ | ​ | ​ | ​ | Quoted Prices in Active | ​ | Significant Other | ​ | Significant
​ | ​ | ​ | ​ | ​ | Markets for Identical | ​ | Observable | ​ | Unobservable
​ | ​ | ​ | ​ | ​ | Assets | ​ | Inputs | ​ | Inputs
​ |  | Total |  | (Level 1) |  | (Level 2) |  | (Level 3)
​ | ​ | (in millions)
Assets | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Plan asset for deferred compensation(1) | ​ | $ | 1.9 | ​ | $ | 1.9 | ​ | $ | — | ​ | $ | —
Interest rate swap(2) | ​ | $ | 9.8 | ​ | $ | — | ​ | $ | 9.8 | ​ | $ | —
Designated foreign currency hedges(4) | ​ | $ | 0.4 | ​ | $ | — | ​ | $ | 0.4 | ​ | $ | —
Total assets | ​ | $ | 12.1 | ​ | $ | 1.9 | ​ | $ | 10.2 | ​ | $ | —
Liabilities | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Plan liability for deferred compensation(3) | ​ | $ | 1.9 | ​ | $ | 1.9 | ​ | $ | — | ​ | $ | —
Contingent consideration(6) | ​ | $ | 5.2 | ​ | $ | — | ​ | $ | — | ​ | $ | 5.2
Total liabilities | ​ | $ | 7.1 | ​ | $ | 1.9 | ​ | $ | — | ​ | $ | 5.2
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Fair Value Measurements at December 31, 2021 Using:
​ | ​ | ​ | ​ | ​ | Quoted Prices in Active | ​ | Significant Other | ​ | Significant
​ | ​ | ​ | ​ | ​ | Markets for Identical | ​ | Observable | ​ | Unobservable
​ |  | ​ | ​ | ​ | Assets | ​ | Inputs | ​ | Inputs
​ | ​ | Total |  | (Level 1) |  | (Level 2) |  | (Level 3)
​ | ​ | (in millions)
Assets | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Plan asset for deferred compensation(1) | ​ | $ | 2.6 | ​ | $ | 2.6 | ​ | $ | — | ​ | $ | —
Interest rate swap(1) | ​ | $ | 1.4 | ​ | $ | — | ​ | $ | 1.4 | ​ | $ | —
Total assets | ​ | $ | 4.0 | ​ | $ | 2.6 | ​ | $ | 1.4 | ​ | $ | —
Liabilities | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Interest rate swap(5) | ​ | $ | 0.6 | ​ | $ | — | ​ | $ | 0.6 | ​ | $ | —
Plan liability for deferred compensation(3) | ​ | $ | 2.6 | ​ | $ | 2.6 | ​ | $ | — | ​ | $ | —
Contingent consideration(6) | ​ | $ | 6.3 | ​ | $ | — | ​ | $ | — | ​ | $ | 6.3
Total liabilities | ​ | $ | 9.5 | ​ | $ | 2.6 | ​ | $ | 0.6 | ​ | $ | 6.3
(1) | Included on the Company’s consolidated balance sheet in other assets (other, net).
​
(2) | As of September 25, 2022, $3.0 million classified in prepaid expenses and other current assets on the Company’s consolidated balance sheet and $6.8 million classified in other assets (other, net).
​
(3) | Included on the Company’s consolidated balance sheet in accrued compensation and benefits.
​ (4)Included on the Company’s consolidated balance sheet in prepaid expenses and other current assets. ​ (5)Included on the Company’s consolidated balance sheet in accrued expenses and other liabilities. ​ (6)As of September 25, 2022, contingent consideration of $5.2 million related to two immaterial acquisitions, of which $2.7 million was classified in accrued expenses and other liabilities and $2.5 million was classified in other noncurrent liabilities on the Company’s consolidated balance sheet. As of December 31, 2021, contingent consideration of $6.3 million related to two immaterial acquisitions, of which $3.8 million was classified in accrued expenses and other liabilities and $2.5 million was classified in other noncurrent liabilities on the Company’s consolidated balance sheet. ​

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAllOtherInvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration